Xenon Pharmaceuticals Inc. — All Filings
752 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
10-Q/A
144
3
3/A
4
4/A
424B4
424B5
8-A12B
8-K
8-K/A
ARS
CERTNAS
CORRESP
CT ORDER
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
S-1
S-1/A
S-3
S-3ASR
S-8
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 144 | — | 0001193125-26-106680 | Mar 13, 2026 | — |
| 4 | 4 | 0001193125-26-106726 | Mar 13, 2026 | Mar 12, 2026 |
| 144 | — | 0001193125-26-106682 | Mar 13, 2026 | — |
| 4 | 4 | 0001193125-26-106724 | Mar 13, 2026 | Mar 12, 2026 |
| 144 | — | 0001193125-26-106681 | Mar 13, 2026 | — |
| 8-K | 8-K | 0001193125-26-106144 | Mar 13, 2026 | — |
| 4 | 4 | 0001193125-26-106727 | Mar 13, 2026 | Mar 12, 2026 |
| 424B5 | 424B5 | 0001193125-26-102517 | Mar 12, 2026 | — |
| 8-K | 8-K | 0001193125-26-104199 | Mar 12, 2026 | Mar 10, 2026 |
| 4 | 4 | 0001193125-26-102666 | Mar 11, 2026 | Mar 9, 2026 |
| FWP | FWP | 0001193125-26-100831 | Mar 11, 2026 | — |
| 4 | 4 | 0001193125-26-102667 | Mar 11, 2026 | Mar 9, 2026 |
| 4 | 4 | 0001193125-26-102669 | Mar 11, 2026 | Mar 9, 2026 |
| 144 | — | 0001193125-26-100799 | Mar 10, 2026 | — |
| 144 | — | 0001193125-26-100797 | Mar 10, 2026 | — |
| 144 | — | 0001193125-26-100805 | Mar 10, 2026 | — |
| 424B5 | 424B5 | 0001193125-26-098764 | Mar 9, 2026 | — |
| 144 | — | 0001193125-26-098734 | Mar 9, 2026 | — |
| 8-K | 8-K | 0001193125-26-097577 | Mar 9, 2026 | — |
| 424B5 | 424B5 | 0001193125-26-082504 | Feb 27, 2026 | — |
| 8-K | 8-K | 0001193125-26-082520 | Feb 27, 2026 | — |
| 10-K | 10-K | 0001193125-26-076650 | Feb 26, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001193125-26-076530 | Feb 26, 2026 | — |
| SCHEDULE 13G | — | 0000902219-26-000084 | Feb 10, 2026 | — |
| 4 | 4 | 0001193125-26-009238 | Jan 9, 2026 | — |
| 4 | 4 | 0001193125-26-009230 | Jan 9, 2026 | — |
| 4 | 4 | 0001193125-26-009235 | Jan 9, 2026 | — |
| 4 | 4 | 0001193125-26-009232 | Jan 9, 2026 | — |
| 144 | — | 0001193125-26-001168 | Jan 2, 2026 | — |
| 4 | 4 | 0001193125-26-001172 | Jan 2, 2026 | — |
| 4 | 4 | 0001193125-25-313147 | Dec 9, 2025 | Dec 5, 2025 |
| 144 | — | 0001193125-25-311409 | Dec 8, 2025 | — |
| 144 | — | 0001193125-25-310009 | Dec 5, 2025 | — |
| 4 | 4 | 0001193125-25-307211 | Dec 3, 2025 | Nov 28, 2025 |
| 8-K | 8-K | 0001193125-25-303862 | Dec 1, 2025 | Nov 24, 2025 |
| S-8 | S-8 | 0001193125-25-303888 | Dec 1, 2025 | — |
| 144 | — | 0001193125-25-304226 | Dec 1, 2025 | — |
| 8-K | 8-K | 0001193125-25-262519 | Nov 3, 2025 | — |
| 10-Q | 10-Q | 0001193125-25-262646 | Nov 3, 2025 | Sep 30, 2025 |
| 4 | 4 | 0001193125-25-242700 | Oct 17, 2025 | Oct 15, 2025 |
| 3 | 3 | 0001193125-25-242698 | Oct 17, 2025 | Oct 15, 2025 |
| 8-K/A | 8-K/A | 0001193125-25-242583 | Oct 17, 2025 | Oct 15, 2025 |
| 8-K | 8-K | 0001193125-25-241546 | Oct 16, 2025 | Oct 15, 2025 |
| 144 | — | 0001193125-25-227196 | Oct 1, 2025 | — |
| 4 | 4 | 0001193125-25-227202 | Oct 1, 2025 | — |
| 144 | — | 0001193125-25-209529 | Sep 19, 2025 | — |
| SCHEDULE 13G/A | — | 0000902219-25-000271 | Aug 12, 2025 | — |
| 8-K | 8-K | 0000950170-25-106529 | Aug 11, 2025 | — |
| 10-Q | 10-Q | 0000950170-25-106599 | Aug 11, 2025 | Jun 30, 2025 |
| SCHEDULE 13G/A | — | 0000315066-25-002142 | Aug 6, 2025 | — |